American Heart Association Scientific Sessions 2026
Amongst the highlights of triglyceride research presented at the American Heart Association Scientific Sessions 2026 (Chicago, USA, 6-9 November) were latest data from the TYDAL-TIMI 78 study of MAR001, the PALISADE and SHASTA-3/4 studies of plozasiran, together with early phase data with the dual action siRNA conjugate, ARO-DIMER-PA, the ANGPTL3 gene editing agent, CTX310, and […]
Read More > American Heart Association Scientific Sessions 2026